Current and historical daily PE Ratio for MEDP (
Medpace Holdings Inc
) from 2016 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Medpace stock (MEDP) PE ratio as of May 22 2024 is 39.74.
More Details
Medpace Holdings Inc (MEDP) PE Ratio (TTM) Chart
Medpace Holdings Inc (MEDP) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1234
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Medpace PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-23 | 39.7 | 2024-03-19 | 43.9 |
| 2024-05-21 | 40.4 | 2024-03-18 | 44.0 |
| 2024-05-20 | 40.5 | 2024-03-15 | 44.7 |
| 2024-05-17 | 40.1 | 2024-03-14 | 45.6 |
| 2024-05-16 | 40.1 | 2024-03-13 | 45.9 |
| 2024-05-15 | 41.4 | 2024-03-12 | 45.9 |
| 2024-05-14 | 40.6 | 2024-03-11 | 45.4 |
| 2024-05-13 | 39.7 | 2024-03-08 | 45.7 |
| 2024-05-10 | 39.8 | 2024-03-07 | 46.1 |
| 2024-05-09 | 40.7 | 2024-03-06 | 46.2 |
| 2024-05-08 | 39.5 | 2024-03-05 | 45.4 |
| 2024-05-07 | 41.0 | 2024-03-04 | 45.3 |
| 2024-05-06 | 40.9 | 2024-03-01 | 45.5 |
| 2024-05-03 | 40.0 | 2024-02-29 | 44.8 |
| 2024-05-02 | 39.9 | 2024-02-28 | 45.4 |
| 2024-05-01 | 40.6 | 2024-02-27 | 45.5 |
| 2024-04-30 | 39.6 | 2024-02-26 | 45.4 |
| 2024-04-29 | 40.8 | 2024-02-23 | 45.2 |
| 2024-04-26 | 40.4 | 2024-02-22 | 44.3 |
| 2024-04-25 | 39.7 | 2024-02-21 | 43.5 |
| 2024-04-24 | 40.5 | 2024-02-20 | 43.3 |
| 2024-04-23 | 41.5 | 2024-02-16 | 44.1 |
| 2024-04-22 | 38.4 | 2024-02-15 | 44.4 |
| 2024-04-19 | 37.9 | 2024-02-14 | 43.9 |
| 2024-04-18 | 38.2 | 2024-02-13 | 41.0 |
| 2024-04-17 | 39.0 | 2024-02-12 | 36.5 |
| 2024-04-16 | 39.3 | 2024-02-09 | 36.8 |
| 2024-04-15 | 39.5 | 2024-02-08 | 35.9 |
| 2024-04-12 | 40.3 | 2024-02-07 | 34.8 |
| 2024-04-11 | 41.0 | 2024-02-06 | 34.1 |
| 2024-04-10 | 40.5 | 2024-02-05 | 33.3 |
| 2024-04-09 | 41.3 | 2024-02-02 | 33.3 |
| 2024-04-08 | 41.7 | 2024-02-01 | 33.2 |
| 2024-04-05 | 40.9 | 2024-01-31 | 32.8 |
| 2024-04-04 | 39.7 | 2024-01-30 | 34.0 |
| 2024-04-03 | 40.4 | 2024-01-29 | 33.9 |
| 2024-04-02 | 40.0 | 2024-01-26 | 33.6 |
| 2024-04-01 | 40.6 | 2024-01-25 | 33.5 |
| 2024-03-28 | 41.2 | 2024-01-24 | 33.4 |
| 2024-03-27 | 45.4 | 2024-01-23 | 33.7 |
| 2024-03-26 | 45.4 | 2024-01-22 | 33.8 |
| 2024-03-25 | 45.3 | 2024-01-19 | 33.3 |
| 2024-03-22 | 46.0 | 2024-01-18 | 32.8 |
| 2024-03-21 | 46.5 | 2024-01-17 | 32.1 |
| 2024-03-20 | 44.9 | 2024-01-16 | 32.3 |
Medpace Holdings Inc (MEDP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Medpace Holdings Inc
NAICS : 541714
SIC : 8731
ISIN : US58506Q1094
Description
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers